273 filings
8-K
FATE
Fate Therapeutics Inc
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
424B5
FATE
Fate Therapeutics Inc
20 Mar 24
Prospectus supplement for primary offering
5:30pm
10-K
2023 FY
FATE
Fate Therapeutics Inc
Annual report
26 Feb 24
4:10pm
8-K
FATE
Fate Therapeutics Inc
26 Feb 24
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
4:03pm
EFFECT
FATE
Fate Therapeutics Inc
28 Nov 23
Notice of effectiveness
12:15am
CORRESP
gzi7eb4n17mqp3s7s
21 Nov 23
Correspondence with SEC
12:00am
UPLOAD
gdgokkdh217 qpr
15 Nov 23
Letter from SEC
12:00am
8-K
sajp0rp07d5w
8 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
qgefgqhxdu
8 Nov 23
Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
4:03pm
8-K
aus u1xslej6fk
1 Sep 23
Other Events
5:29pm
8-K
w4977d8hwe8y
8 Aug 23
Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
4:07pm
8-K
1fiy8jfpk 9gy9
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
8flse fm4g23
8 Jun 23
Departure of Directors or Certain Officers
4:12pm
8-K
knig644p
7 Jun 23
Other Events
8:52am
8-K
osqefw5ib8ttdumm
3 May 23
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
4:06pm
ARS
7x7nycz
21 Apr 23
Annual report to shareholders
4:08pm